433 related articles for article (PubMed ID: 27477685)
21. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.
Abeti R; Zeitlberger A; Peelo C; Fassihi H; Sarkany RPE; Lehmann AR; Giunti P
Br J Pharmacol; 2019 Nov; 176(22):4293-4301. PubMed ID: 30499105
[TBL] [Abstract][Full Text] [Related]
22. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge.
Riancho J; Delgado-Alvarado M; Andreu MD; Paz-Fajardo L; Arozamena S; Gil-Bea FJ; López de Munaín A
Br J Pharmacol; 2021 Mar; 178(6):1269-1278. PubMed ID: 32497246
[TBL] [Abstract][Full Text] [Related]
23. The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.
Tarafdar A; Pula G
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513656
[TBL] [Abstract][Full Text] [Related]
24. Antioxidant effects of resveratrol in the cardiovascular system.
Xia N; Daiber A; Förstermann U; Li H
Br J Pharmacol; 2017 Jun; 174(12):1633-1646. PubMed ID: 27058985
[TBL] [Abstract][Full Text] [Related]
25. Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis.
Klingl YE; Pakravan D; Van Den Bosch L
Br J Pharmacol; 2021 Mar; 178(6):1353-1372. PubMed ID: 32726472
[TBL] [Abstract][Full Text] [Related]
26. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease.
Corona JC; Duchen MR
Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979
[TBL] [Abstract][Full Text] [Related]
27. The proteostasis network provides targets for neurodegeneration.
Newton TM; Duce JA; Bayle ED
Br J Pharmacol; 2019 Sep; 176(18):3508-3514. PubMed ID: 30820936
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches.
Cipak Gasparovic A; Zarkovic N; Zarkovic K; Semen K; Kaminskyy D; Yelisyeyeva O; Bottari SP
Br J Pharmacol; 2017 Jun; 174(12):1771-1783. PubMed ID: 27864827
[TBL] [Abstract][Full Text] [Related]
29. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
[No Abstract] [Full Text] [Related]
30. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.
Surace MJ; Block ML
Cell Mol Life Sci; 2012 Jul; 69(14):2409-27. PubMed ID: 22581365
[TBL] [Abstract][Full Text] [Related]
31. Thiol redox homeostasis in neurodegenerative disease.
McBean GJ; Aslan M; Griffiths HR; Torrão RC
Redox Biol; 2015 Aug; 5():186-194. PubMed ID: 25974624
[TBL] [Abstract][Full Text] [Related]
32. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
33. Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis.
Riancho J; Paz-Fajardo L; López de Munaín A
Br J Pharmacol; 2021 Mar; 178(6):1257-1268. PubMed ID: 32673410
[TBL] [Abstract][Full Text] [Related]
34. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial metals as a potential therapeutic target in neurodegeneration.
Grubman A; White AR; Liddell JR
Br J Pharmacol; 2014 Apr; 171(8):2159-73. PubMed ID: 24206195
[TBL] [Abstract][Full Text] [Related]
36. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
Tabassum R; Jeong NY
Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
[TBL] [Abstract][Full Text] [Related]
37. Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.
Shadfar S; Parakh S; Jamali MS; Atkin JD
Transl Neurodegener; 2023 Apr; 12(1):18. PubMed ID: 37055865
[TBL] [Abstract][Full Text] [Related]
38. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
39. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
Denzer I; Münch G; Friedland K
Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review.
Abrahams S; Haylett WL; Johnson G; Carr JA; Bardien S
Neuroscience; 2019 May; 406():1-21. PubMed ID: 30825584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
